# Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance), Division (c): Control tests on the finished medicinal product

Extent: E+W+S+N.I.

The general quality requirements shall apply to the homeopathic finished veterinary medicinal products. Any exception shall be duly justified by the applicant.
Identification and assay of all the toxicologically relevant constituents shall be carried out. If it can be justified that identification and/or an assay on all the toxicologically relevant constituents is not possible e.g. due to their dilution in the finished medicinal product the quality shall be demonstrated by complete validation of the manufacturing and dilution process.

---
Source: https://www.legislation.gov.uk/eur/2019/6/annex/II/title/IV/division/2/part/2/division/c (the official version)
Page: https://openlegislation.uk/eu-regulation-2019-6/annex-II/title-IV/division-2/part-2/division-c
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

